Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain-type creatine phosphokinase serum levels before and after ECT.

M G Webb, M P O'Donnell, R J Draper

    The British Journal of Psychiatry : the Journal of Mental Science
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dual-energy CT material decomposition in the presence of nonuniqueness.

    Physics in medicine and biology·2025
    Same author

    The structure of liquid carbon elucidated by in situ X-ray diffraction.

    Nature·2025
    Same author

    Non-unique water and contrast agent solutions in dual-energy CT.

    ArXiv·2024
    Same author

    Comparison of non-invasive peripheral venous saturations with venous blood co-oximetry.

    Journal of clinical monitoring and computing·2016
    Same author

    Abstracts of the proceedings of the 20th annual meeting of the irish neurological association held on 25th-26th may, 1984.

    Irish journal of medical science·2016
    Same author

    The effect of vascular changes on the photoplethysmographic signal at different hand elevations.

    Physiological measurement·2015
    Same journal

    Hormone blindness in precision psychiatry.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    What is a clinical trial? A proposal for expanding the WHO definition of a clinical trial for use in mental health research.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Artificial intelligence evolution in medicine.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Relapse and the outcome of schizophrenia and recurrent psychosis: response to a Commentary.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Psilocybin therapy for adult females with anorexia nervosa: pilot study.

    The British journal of psychiatry : the journal of mental science·2026
    Same journal

    Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

    The British journal of psychiatry : the journal of mental science·2026
    See all related articles

    Electroconvulsive therapy (ECT) did not significantly change serum levels of brain-type creatine phosphokinase (CPK BB) in depressed patients. This suggests ECT does not alter blood-brain barrier permeability or cause detectable brain injury.

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Psychiatry

    Background:

    • Brain-type creatine phosphokinase (CPK BB) is an enzyme primarily found in the brain.
    • Elevated CPK BB levels can indicate brain injury or blood-brain barrier disruption.
    • Electroconvulsive therapy (ECT) is a treatment for severe depression, but its potential effects on brain tissue are of interest.

    Purpose of the Study:

    • To investigate whether electroconvulsive therapy (ECT) affects serum concentrations of brain-type creatine phosphokinase (CPK BB).
    • To assess potential changes in blood-brain barrier permeability or detectable brain injury following ECT.

    Main Methods:

    • Serum CPK BB levels were measured using radioimmunoassay in 31 depressed patients.
    • Blood samples were collected before and at 1, 2, and 6 hours after bilateral ECT.

    Related Experiment Videos

  • Pre-ECT CPK BB levels were compared between patients receiving their first ECT and those receiving subsequent treatments.

    • Main Results:

    • No significant alteration in serum CPK BB concentration was observed during the six hours post-ECT.
    • No significant difference in mean pre-ECT CPK BB levels was found between first-time and subsequent ECT recipients.
    • These findings indicate no immediate detectable brain injury or blood-brain barrier disruption due to ECT.

    Conclusions:

    • ECT does not appear to cause significant changes in serum CPK BB levels in the immediate post-treatment period.
    • The study's results do not support the hypothesis that ECT alters blood-brain barrier permeability or causes detectable brain injury.
    • Further research may explore longer-term effects or different biomarkers of brain integrity after ECT.